Every earnings season, the headlines trumpet what analysts expect. But the filings related to insider trades that most skim ...

Key Points Analyst expectations are far above the prices you'd need to pay now to own a couple of biotechnology stocks.Compass Pathways is developing psilocybin as a treatment for depression.Viking ...

These five stocks with monthly dividends are trading under $10, making them tremendous bargains for investors seeking passive ...

Key Points Qualcomm has struggled amid the upcoming loss of a major customer and heavy China exposure.The company's emerging product lines arguably give investors good reason to take advantage of its ...

Investors will be watching for dovish sentiment in central bank commentary and results from Alphabet and Tesla, as the local ...

The industrial sector has led the way for U.S. equities during a topsy-turvy year on Wall Street, but its strength will be ...

Deathcare has grown to a $126 billion industry, and digital technology startups are changing the landscape for institutions ...

It has become increasingly clear that Apple cannot catch up to AI market leaders. Every day, it falls further behind. It may ...

A Stellar Surge in the Space Stock’s Price AST SpaceMobile (NASDAQ:ASTS) has captured investor attention with a meteoric rise ...

In the week ahead, 112 S&P 500 companies are set to report quarterly results, with earnings season in full focus as the ...

As of June 30, analysts projected S&P 500 earnings to grow 4.9% year over year in the second quarter, according to FactSet. That estimate was revised up to 5.6% as of July 18. Even so, if earnings ...

US stock market predictions for S&P 500, Nasdaq, and Dow Jones are out and it will be testing week at the Wall Street for ...